|Bid||0.00 x 1200|
|Ask||0.00 x 900|
|Day's Range||42.50 - 44.00|
|52 Week Range||41.12 - 57.40|
|Beta (3Y Monthly)||1.77|
|PE Ratio (TTM)||14.30|
|Earnings Date||Jan 31, 2019 - Feb 4, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||54.39|
Today's bell ringers are Yeti Holdings with CEO and president Matthew Reintjes at the NYSE, and StoneCo Ltd. with CEO Thiago Piau at the Nasdaq.
At Insider Monkey, we pore over the filings of more than 700 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we’ve gathered as a result gives us access to a wealth of collective knowledge based on these firms’ portfolio holdings as of September 30. In […]
The “Internet of Things” is already a fairly well-known term, but by next year, I expect it will be a phrase used in every household. The reach of the IoT is massive, which should might have investors asking themselves what are some good Internet of Things stocks to buy? IoT includes the commonly thought of devices like smartphones and televisions, as well as new possibilities such as thermostats, automobiles and even street lights.
The U.K.-based maker of sensors and controls continues to make non-auto M&A deals. Investor pessimism over the global auto market has hurt the stock.
Company to Webcast Presentation Live at 8:00 a.m. ET on Tuesday, November 13th SWINDON, United Kingdom, Nov. 08, 2018 -- Sensata Technologies (NYSE: ST) today announced that.
Sensata (ST) delivered earnings and revenue surprises of 0.00% and 1.42%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Swindon, Britain-based company said it had profit of 88 cents per share. Earnings, adjusted for non-recurring costs, were 91 cents per share. The results met Wall Street expectations. The average estimate ...
SWINDON, United Kingdom, Oct. 30, 2018 -- Sensata Technologies (NYSE:ST), a global industrial technology company and a leading provider of sensors, today announced financial.
Sensata Technologies Holding PLC (ST) was incorrectly omitted from the Biggest 1,000 Stocks tables published from March 29 to Oct. 20. As of Sept. 28, the one-year return of Union Street Partners Value Fund Advisor Class (USPFX) was 16.
Sensata (ST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors’ mounting worries about the health of the global auto market have dented shares of Sensata Technologies. That could be an opportunity for patient investors.
SWINDON, United Kingdom, Oct. 09, 2018 -- Sensata Technologies (NYSE:ST) today announced that it will disclose its third quarter 2018 financial results on Tuesday, October 30,.
The once red-hot semiconductor sector is slowing down, with one team of analysts cutting their stock estimates for the first time in three years. In a recent research note, Morgan Stanley analyst Craig Hettenbach lowered his estimates for the chip sector in the fourth quarter and the year ahead. Hettenbach also reduced his price forecast for seven stocks including Qorvo Inc. ( QRVO), Microchip Technology Inc. ( MCHP), and TE Connectivity Ltd. ( TEL).
Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as Sensata Technologies Holding PLC (NYSE:ST), with a market cap of US$8.61b, often Read More...
Sensata Technologies (ST), an industrial technology company and a leading provider of sensors, today announced that it has reached an agreement to acquire privately-held GIGAVAC, LLC for an enterprise value of approximately $233 million, funded out of the company’s cash balances. Based in Carpinteria, California, GIGAVAC has more than 270 employees and is a leading provider of solutions that enable electrification in demanding environments. Its high-value, mission-critical products are used by more than 1,500 customers in complex and challenging applications within the automotive, battery storage, industrial, and heavy vehicle & off road markets and overlap with Sensata’s global customer base.
Medical Prognosis Institute A/S and Oncology Venture AB (ST) ("OV" or the "Company") and Oncology Venture US Inc today announced that the US Food and Drug Administration (FDA) has accepted its Investigational Device Exemption (IDE) and its Investigational New Drug Application (IND) to begin a Phase 2 clinical trial in advanced ovarian cancer with 2X-121 -a PARP inhibitor- using it`s Drug Response Predictor - DRP - to select patients with high likelihood of responding to the treatment. The 2X-121 DRP has a gene signature consisting of more than 400 genes.
The Swindon, Britain-based company said it had net income of 61 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, were 93 cents per share. The results matched Wall Street ...
NEW YORK, NY / ACCESSWIRE / July 24, 2018 / Sensata Technologies Holding plc (NYSE: ST ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 24, 2018 at 8:00 AM Eastern ...